Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

656
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
656
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

557
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
557
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.0K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.7K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Pneumonia IV: Management01:28

Pneumonia IV: Management

845
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
845

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

National outpatient antibiotic prescriptions in Cyprus, 2020-2022.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2025
Same author

Evaluating Greek pharmacists' attitudes and barriers regarding medicines adherence.

Journal of pharmaceutical policy and practice·2024
Same author

The efficiency of TAVI in intermediate and low-risk Japanese patients.

Journal of medical economics·2024
Same author

Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus.

PharmacoEconomics - open·2024
Same author

Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture <i>fat and happy</i> stand true?

Journal of medical economics·2024
Same author

Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?

Journal of medical economics·2023
Same journal

Real-World Evidence in Asian Health Technology Assessment: Evolving Roles, Practices, and Future Directions (2015-2024).

Value in health regional issues·2026
Same journal

Evaluation of the Clinical Effectiveness and Cost-Effectiveness of Tirzepatide for Type 2 Diabetes in Canada Using Bayesian Transportability Analysis.

Value in health regional issues·2026
Same journal

Cost-Effectiveness of Vaccine for the Prevention of Herpes Zoster in Kidney Transplant Recipients in Thailand.

Value in health regional issues·2026
Same journal

Reliability and Validity of Swedish Versions of the Diabetes Self-Management Questionnaire and the Diabetes Distress Scale.

Value in health regional issues·2026
Same journal

Japanese Encephalitis Vaccine Preferences and Uptake in Western Travelers and Locals: Strategies to Enhance Vaccine Uptake.

Value in health regional issues·2026
Same journal

Geospatial Analysis of HIV Prevalence and Cervical Cancer Screening Coverage in Sub-Saharan Africa: Opportunities and Gaps for Integrated Care.

Value in health regional issues·2026
See all related articles

Related Experiment Video

Updated: Feb 20, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K

Battling Tuberculosis beyond antibiotics.

Panagiotis Petrou1

  • 1Pharmacoepidemiology-Pharmacovigilance, University of Nicosia, School of Sciences and Engineering, Pharmacy School.

Value in Health Regional Issues
|October 28, 2017
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) incidence in Cyprus has doubled, driven by a legislative gap excluding high-risk European migrants from mandatory screening. Reforming health policies with epidemiological data is crucial for effective TB control.

Keywords:
Cyprushealth policymigrationtuberculosis

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.1K

Related Experiment Videos

Last Updated: Feb 20, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.3K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

9.1K

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Control

Background:

  • Tuberculosis (TB) incidence in Cyprus has doubled in the past decade.
  • An urgent need exists to overhaul current strategies to control TB spread.
  • The rising TB rates necessitate a comprehensive analysis of contributing factors.

Purpose of the Study:

  • To analyze the incidence of tuberculosis (TB) in Cyprus based on nationality, age, and sex.
  • To provide insights into the current TB pattern within Cyprus.
  • To identify demographic and legislative factors influencing TB incidence.

Main Methods:

  • Odds ratio statistical analysis was performed on recent TB data.
  • The study examined associations between nationality and increased TB incidence.
  • Data analysis focused on identifying patterns in TB cases.

Main Results:

  • Certain nationalities showed a significant association with the rise in TB incidence.
  • A legislative gap was identified, making screening mandatory only for third-country migrants.
  • High-risk European migrants are not covered by current mandatory screening provisions.

Conclusions:

  • Health policies for TB in Cyprus require reform.
  • Epidemiological findings should be integrated into a revised, comprehensive policy.
  • Reformed policies will enhance efficiency and conserve resources for TB control.